**Question:** Drug used for obesity:

A. Orlistat
B. Roux-en-Y Gastric Bypass
C. Metformin
D. Sibutramine

**Core Concept:**
Obesity is a complex condition characterized by excessive body fat accumulation that can lead to negative health consequences. Several pharmacological treatments are available to aid in weight management. Orlistat, Roux-en-Y Gastric Bypass, Metformin, and Sibutramine are among the drugs used for obesity treatment.

**Why the Correct Answer is Right:**

D. Sibutramine (Meridia) is a selective reuptake inhibitor of serotonin and norepinephrine, which increases serotonin and norepinephrine levels in the synaptic cleft, leading to reduced food intake and decreased appetite. It is primarily used for long-term weight management in obese patients with co-morbidities.

**Why Each Wrong Option is Incorrect:**

A. Orlistat (Xenical) is a lipase inhibitor that works by blocking the absorption of fat in the gastrointestinal tract, limiting the amount of fat that enters the bloodstream and reducing calorie intake. While effective in reducing body weight, it is not primarily designed for long-term weight management but rather for short-term weight loss in obese patients.

B. Roux-en-Y Gastric Bypass (RYGB) is a surgical procedure performed in severely obese patients to reduce the stomach volume and divert the food flow, bypassing a portion of the small intestine. It is a highly effective intervention for weight loss but is not typically considered as a pharmacological treatment option.

C. Metformin (Glucophage) is an antidiabetic medication primarily used for the management of type 2 diabetes. While it has been shown to have some weight loss effects, it is not specifically designed for weight management and is not considered the first-line pharmacological option for obesity treatment.

**Clinical Pearl:**

Surgical procedures like Roux-en-Y Gastric Bypass are considered first-line treatment options for obesity, and pharmacological treatments like Orlistat and Metformin are often used as adjunctive therapies. However, Sibutramine (Meridia) is a more selective and targeted approach for weight management, as it directly targets appetite suppression and fat absorption.

**Correct Answer Explanation:**

The correct answer is Sibutramine (Meridia), as it is a selective and targeted pharmacological agent designed for weight management by suppressing appetite and inhibiting fat absorption. While Orlistat, Roux-en-Y Gastric Bypass, and Metformin have their respective uses in obesity management, they are not as specific to weight management as Sibutramine. Roux-en-Y Gastric Bypass is a surgical procedure, Orlistat reduces fat absorption, Metformin is an antidiabetic drug, and Sibutramine directly targets appetite suppression and fat absorption, making it a more suitable choice for weight management compared to the other options.

**Why Other Options Might Be Used:**

Orlistat (